InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,175.20
(
0.00%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.39
(
0.24%
)
Bitcoin
61,624.35
(
-0.30%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: nmbr1stckpckr post# 30187

Thursday, 03/10/2011 10:43:24 AM

Thursday, March 10, 2011 10:43:24 AM

Post# of 92948
well, first example was 2 months and here are a couple others that PR'd "positive opinion" that have yet to announce approval. Recent examples that one would think can serve as a guide, but who knows.

ZIOPHARM Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency
Jan 20, 2011
http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=544639

01/25/11 Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=irol-newsArticle_Print&ID=1519451&highlight=
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up